Incannex Healthcare (IXHL) Total Liabilities (2020 - 2026)
Incannex Healthcare (IXHL) posted Total Liabilities of $5.0 million for Q1 2026, up 215.56% sequentially from $1.6 million in Q4 2025, and down 42.59% YoY from $8.8 million in Q1 2025.
Incannex Healthcare (IXHL) Total Liabilities (2020 - 2026) Analysis & Trends
Incannex Healthcare has reported Total Liabilities for 7 years, with the latest figure at $5.0 million in Q1 2026.
- Quarterly Total Liabilities fell 42.59% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (down 42.59% YoY) and the FY2025 annual result came in at $7.1 million, up 21.06% from the prior year.
- Total Liabilities advanced to $5.0 million in Q1 2026 per IXHL's latest filing, from $1.6 million in the prior quarter.
- Over five years, Total Liabilities peaked at $10.1 million in Q4 2024 and troughed at $1.3 million in Q4 2022.
- A 5-year average of $4.8 million and a median of $3.5 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities jumped 190.82% in 2024, then plunged 84.22% in 2025.
- Over 5 years, Total Liabilities stood at $1.3 million in 2022, then soared by 168.0% to $3.5 million in 2023, then surged by 190.82% to $10.1 million in 2024, then slumped by 84.22% to $1.6 million in 2025, then soared by 215.56% to $5.0 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $5.0 million, $1.6 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | Incannex Healthcare | 43.22 Mn | 43.22 Mn | - | 5.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.05 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 7.06 Mn |
| Mar 31, 2025 | 8.79 Mn |
| Dec 31, 2024 | 10.14 Mn |
| Sep 30, 2024 | 9.45 Mn |
| Jun 30, 2024 | 5.83 Mn |
| Mar 31, 2024 | 3.11 Mn |
| Dec 31, 2023 | 3.49 Mn |
| Jun 30, 2023 | 2.96 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Jun 30, 2022 | 2.01 Mn |
| Jun 30, 2021 | 755,049.00 |
| Jun 30, 2020 | 1.07 Mn |